GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2021-09-28| COVID-19

Sanofi Abandons mRNA-Based COVID-19 Vaccine Plan but Indian Biotechs March On

by Daniel Ojeda
Share To
mRNA vaccines are the breakout technology from the COVID-19 pandemic. Although the scientific advances have been decades in the making, the pandemic presented the opportunity for the modality to demonstrate its safety and efficacy in general populations.

This technology also launched companies like Moderna and BioNTech to new highs as their vaccines emerged first on the market, allowing them to attain market dominance. Pfizer and BioNTech alone have delivered close to 1.5 billion doses of their COVID-19 vaccine and forecasts suggest their COVID-19 vaccine sales will reach $33.5 billion in 2021. 

At this juncture, entering the vaccine market is complicated, expensive, and risky for companies. For this reason, French pharma giant, Sanofi announced it would drop its plans for its mRNA-based COVID-19 vaccine despite obtaining positive trial results. Nevertheless, India’s biotech companies are looking to capitalize on this market in lower and middle-income countries that Pfizer and Moderna have overlooked.

GO Prime with only $1.49 now

LATEST
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation
2025-02-11
Trump’s Trade War Shake-Up: How U.S. Tariffs Could Disrupt Global Pharma
2025-02-10
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top